thank experienced Scott. off our our the delivered Building in performance, Health morning, XXXX. Thanks, continued as Good results quarter quarter Pain quarter Recovery shifts we second its you everyone, results, second and and for financial a and business. operational we first to additional Digestive for review positive us joining strong our solid and Management
XX remain above improve past in in to eliminating the our prior and effectively will progresses. we commercial noted normal months. the strategy, as our is our strong, backlog experienced XXXX earnings organization our for year products we demand quarterly our As calls this significant supply the performance year, support executing The chain for
things transformation discuss is against both as progress our customers. the further. priorities, the patients which that will focus and are We Michael matter as to meet continuing steady our needs getting to we primary each of always, back And I on of make our
impact transformation to sales portfolio of our per streams not our adjusted effects foreign adjusted ago. discontinued by $XX compared to diluted our million. $XXX priority, operations. the specified We revenue up quarter, X.X% the exchange Adjusted strategic operations approximately continuing were that continuing sales from return and year of the of for organic million the and decision For from share criteria did were EBITDA approximately generated $X.XX earnings of meet a
transformation X-year our we execution to that provided Day. quarter can evidence ranges year continue Investor our Our deliver of last the within priorities financial drive XXXX and our further the we second established during targets results
level. the minutes our Now next product I'll few discussing category spend of results the
double reaffirming portfolio versus growing Digestive almost This excellent continues bolstered NeoMed in feeding. was of line, North demand and our organically NeoMed to results, in prior Our terrific versus position Health strong long X% continue short performance the America. deliver year, our to prior we the quarter, digits as which conversions term, year by take posted another #X advantage ENFit for term product growing
the late growth growth While still the the have as next we we over stages we we solid adoption. as but of product the few and enter line are lower anticipate experiencing currently signaled, above NeoMed double-digit previously quarters market infant for
strong business single digits the also quarter, year. a to legacy neutropenic Our compared posted growing previous high
opportunities. of innovations launch attractive during call, noted into growth the global supported to for back additional actionable planning launched the completion low-growth our markets year, Digestive of last are expansion growth we anticipate and portfolio As above-market continued with M&A year, quarter this product we our during rationalization this by and the Health half prospects, have
acquisition. related Management sales excluding to Pain to Normalized Recovery quarter this turning portfolio. our inorganic Now for our Diros and HA were X%, up and sales organic approximately
revenue, the which point down same grew less period, and performance the of digits testament with for business On-Q portfolio positive surgical portfolio portfolio year-over-year, strategy While enhanced pain we Even ON-Q quarter portfolio, growing to our without the for Diros previous of digits renewed combined impact pleased our the frequency combined compared the focus go-to-market this was by returned ambIT. on IVP mid-single our a than ambIT with to year. ablation our our overall and radio and X growth by to this were mid-single
the We are procedural encouraged generator seen sales IVP by capturing continued in momentum by volumes. higher our accompanied
new strategy these fully our productivity credit structure outcomes. our We ASC supporting Further meaning strategy, and of line our ASC the supporting to deliver, acquired Diros and internal new expectations. transaction sales our renewed increasing Trident deployed product our continues the growth
having U.S. accounts converted market over to launch We with technology. successful are Trident on our XXX capitalizing our
strong Our lower also We slightly in the growth in Game to consecutive of Ready especially the Game profile year, quarter particularly had the we half XXXX. compared growth is double-digit back Ready year. the strong second a given from anticipate demonstrating portfolio fourth momentum a posting quarter prior
X remain in portfolio, revenue of anticipated ability the Finally, on price as HA in to This HA with to HA categories stabilizes. portfolio strategies longer-term in mid- year. previously quarter this the our level decrease our prior XX% was execute off while full We confident we gain to flat X than revenue shot our as with consistent leveling down in X our year-over-year, performance and maintain and for and share of was aligns results. sequentially XX% our more forecasted HA
by these momentum deliver excluding to XXXX, the the decline just of seeing growth mid-single-digit noted. are indicators I revenue progress in our we solid each encouraged are We ability the XX% across and for are businesses of HA pain and believe
moving Now XXXX transformation to our to efforts. XXXX and priorities
profiles management win, measures improve efficient portfolio meaningfully to where path focus and on continuing have our cost to our financial the that priorities right profitability and X of capital have attractive enhance strategically are product allocation margin ROIC. optimizing categories our As our we organization, taking meaningfully to our opportunities go-to-market years commercially profile. a X additional enhance transforming next reminder, These to for expected are improve we operating and and our to priorities the key
our substantial transformation continue We make against priorities. to progress
progress the Respiratory to towards full our related our and conservative management execution a highlights line, efforts and and Further office Health of portfolio, certain across optimization new our business. execution pain of leverage product discipline with of continued associated separation finalizing divestiture strong than the our Trident Second include quarter our manufacturing of level maintaining Xx. company-wide programs, M&A footprint cost less continuing with
order Our over second progress results results to against testament the coming and of our to priorities, a transformation delivering quarters continued meet quarter on are we XXXX focused our financial consistent remain targets. the in each
I'll transformation platform. call the will results who and Now our Michael, financial to turn over on further insights provide